6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 18C49
Book a meeting

FARMAUSA

About FARMAUSA

The first pharmaceutical company authorized by ANVISA to produce Active Pharmaceutical Ingredient (API) of Medicinal Cannabis.FarmaUSA Life Science Laboratory is approved by the Brazilian Health Regulatory Agency (ANVISA) for the manufacture of controlled substances. We have obtained all the regulatory authorizations required for the sale, storage and distribution of controlled medicines and supplies.

Read more Show less
Certifications
  • GMP
    GMP
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 18C49
  • Country/Region:
    Brazil
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
API Producer
Contact info
  • 11976194344
  • Website
  • Av. Guido Caloi, 1935 – Bloco B – 2 andar, Cond. Master Labs – bairro Jardim São Luis, 05802-140, São Paulo, Rio de Janeiro, Brazil
Show contact info Hide contact info

Products from FARMAUSA (2)

  • API CANNABIDIOL

    Product API CANNABIDIOL

    First pharmaceutical industry with certification GMP API Cannabidiol
  • SUPPLEMENTS

    Product SUPPLEMENTS

    Development of formulations for softgel nutritional supplements

FARMAUSA Resources (1)